跳至主要内容
临床试验/NL-OMON42142
NL-OMON42142已完成不适用

The regenerative surgical treatment of intra-bony peri-implantitis defects with Endobon® (test) versus an established bovine derived bone mineral (control) - Endobon versus BioOss

Vrije Universiteit0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • During surgical exploration an intra-bony component of at least 3 mm at the deepest point must be present.
  • The defect should have a minimum of 3 osseous walls (a circumference of the osseous defect of at least 270 degrees). Only 3 and 4 wall intraosseous defects will be included.
  • The defect must not be wider than 4 mm and the defect angle must be less than 35 degrees from axis of implant.

排除标准

  • Subjects with diabetes mellitus (HbAlc >= 6.5%)
  • Subjects taking corticosteroids or other anti-inflammatory prescription drug
  • Subjects taking medications known to induce gingival hyperplasia
  • Subjects must not be allergic to penicillin or metronidazole
  • Subjects with a history of taking systemic antibiotics in the preceding month
  • Subjects must not be pregnant or lactating
  • Implants placed in grafted bone or previously augmented with bone substitute or other type of regenerative material
  • If stability of the Endobon® granules or control granules cannot be accomplished in the defect
  • Failure of obtaining soft tissue closure
  • Mobile implants

研究者

相似试验